Chemical Structure : BTX-1188
CAS No.: 2560577-69-5
货号: PC-23063Not For Human Use, Lab Use Only.
Sontigidomide (BTX-1188) is a first-in-class dual degrader of GSPT1 and IKZF1/3 with DC50 of 0.2 nM, 1 nM and 1 nM for GSPT1, IKZF1 and IKZF3 respectively, in DOHH-2 (lymphoma) cells.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥2580 | In stock | |
| 10 mg | ¥3980 | In stock | |
| 25 mg | ¥5980 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Sontigidomide (BTX-1188) is a first-in-class dual degrader of GSPT1 and IKZF1/3 with DC50 of 0.2 nM, 1 nM and 1 nM for GSPT1, IKZF1 and IKZF3 respectively, in DOHH-2 (lymphoma) cells.
BTX-1188 potently inhibits AML and solid tumor cell proliferation.
Sontigidomide (BTX-1188) potently inhibits aCD3-stimulated and LPS-induced cytokine induction in human PBMCs.
BTX-1188 is cytotoxic in various cancer cell lines such as MYC-dependent and non-MYC dependent lines (IC50 range: 0.5-20 nM) and primary human AML patient samples (IC50 range: 0.4-1.5 nM), including relapsed/refractory-, cytarabine and Venetoclax-resistant samples.
BTX-1188 (25 mg/kg, i.p. QD) is highly efficacious in NCI H1155 (NSCLC) xenograft model in BALB/c nude mice.
| 分子量 | 513.47 | |
| 分子式 | C26H22F3N3O5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
N-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]-alpha-oxo-4-[1-(trifluoromethyl)cyclopropyl]benzeneacetamide |
|
1. Patent US20200369679 A1
2. Aparajita Hoskote Chourasia, et al. Meeting Abstract: 2022 ASCO Annual Meeting I
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright